KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 131 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $43,000 | -47.6% | 6,000 | -47.1% | 0.00% | -33.3% |
| Q2 2017 | $82,000 | +121.6% | 11,335 | +88.9% | 0.00% | +50.0% |
| Q1 2017 | $37,000 | +5.7% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $35,000 | +9.4% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $32,000 | -20.0% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $40,000 | +33.3% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $30,000 | – | 6,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Old West Investment Management, LLC | 1,068,719 | $3,633,000 | 1.50% |
| Abrams Capital Management | 9,108,867 | $30,970,000 | 0.82% |
| Baupost Group | 25,791,678 | $87,692,000 | 0.67% |
| Bristol Advisors, LLC | 51,100 | $174,000 | 0.29% |
| RICE HALL JAMES & ASSOCIATES, LLC | 2,228,059 | $7,575,000 | 0.27% |
| NEXTHERA CAPITAL LP | 200,000 | $680,000 | 0.13% |
| LINCOLN CAPITAL CORP | 37,280 | $127,000 | 0.10% |
| Meridian Wealth Management, LLC | 49,600 | $169,000 | 0.07% |
| Rubric Capital Management LP | 199,883 | $680,000 | 0.07% |
| Virtus ETF Advisers LLC | 155,009 | $527,000 | 0.05% |